Lv5
908 积分 2025-03-03 加入
Systematic analytical workflow for characterisation and identification of partially reduced species in monoclonal antibody manufacturing
8个月前
已完结
Considerations for Updates to ICH Q1 and Q5C Stability Guidelines: Embracing Current Technology and Risk Assessment Strategies
8个月前
已完结
Analysis of immunoglobulin glycosylation by LC‐ESI‐MS of glycopeptides and oligosaccharides
8个月前
已完结
Analysis of Nonhuman N-Glycans as the Minor Constituents in Recombinant Monoclonal Antibody Pharmaceuticals
8个月前
已完结
Acceptable changes in quality attributes of glycosylated biopharmaceuticals
8个月前
已完结
Galactosylation variations in marketed therapeutic antibodies
8个月前
已完结
Determination of isoelectric points and relative charge variants of 23 therapeutic monoclonal antibodies
8个月前
已完结
Rapid assessment of oxidation via middle-down LCMS correlates with methionine side-chain solvent-accessible surface area for 121 clinical stage monoclonal antibodies
8个月前
已完结
Characterization of 30 therapeutic antibodies and related products by size exclusion chromatography: Feasibility assessment for future mass spectrometry hyphenation
8个月前
已完结
皖公网安备34019202002308
